Atlas Trials

Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament

Clinical trial NCT01002170 · COMPLETED

Trial details

NCT number
NCT01002170
Sponsor
Taipei Medical University WanFang Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Pulmonary Tuberculosis
Start date
2009-05-01
Primary completion
2009-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.